Related Experiment Video
Updated: Jun 27, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Regulation of RAF family kinases: new insights from recent structural and biochemical studies
Russell Spencer-Smith1, Deborah K Morrison1
1Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702, U.S.A.
Abstract:
The RAF kinases are required for signal transduction through the RAS-RAF-MEK-ERK pathway, and their activity is frequently up-regulated in human cancer and the RASopathy developmental syndromes. Due to their complex activation process, developing drugs that effectively target RAF function has been a challenging endeavor, highlighting the need for a more detailed understanding of RAF regulation. This review will focus on recent structural and biochemical studies that have provided 'snapshots' into the RAF regulatory cycle, revealing structures of the autoinhibited BRAF monomer, active BRAF and CRAF homodimers, as well as HSP90/CDC37 chaperone complexes containing CRAF or BRAFV600E. In addition, we will describe the insights obtained regarding how BRAF transitions between its regulatory states and examine the roles that various BRAF domains and 14-3-3 dimers play in both maintaining BRAF as an autoinhibited monomer and in facilitating its transition to an active dimer. We will also address the function of the HSP90/CDC37 chaperone complex in stabilizing the protein levels of CRAF and certain oncogenic BRAF mutants, and in serving as a platform for RAF dephosphorylation mediated by the PP5 protein phosphatase. Finally, we will discuss the regulatory differences observed between BRAF and CRAF and how these differences impact the function of BRAF and CRAF as drivers of human disease.
Insights
Understanding RAF kinase regulation is key for developing cancer drugs. Recent structural studies reveal how RAF proteins switch between inactive and active states, offering new therapeutic targets.
Area of Science:
- Molecular Biology
- Biochemistry
- Structural Biology
Background:
- RAF kinases are crucial for the RAS-RAF-MEK-ERK signaling pathway.
- Dysregulated RAF activity is implicated in human cancers and RASopathy syndromes.
- Targeting RAF kinases is challenging due to their complex activation mechanisms.
Purpose of the Study:
- To review recent structural and biochemical studies on RAF kinase regulation.
- To elucidate the mechanisms of RAF activation and deactivation.
- To highlight differences between BRAF and CRAF regulation in disease.
Main Methods:
- Analysis of structural data from autoinhibited BRAF monomers, active RAF homodimers, and chaperone complexes.
- Biochemical studies investigating RAF domain functions and 14-3-3 dimer interactions.
- Examination of HSP90/CDC37 chaperone complex roles and PP5 phosphatase activity.
Main Results:
- Revealed structures of autoinhibited BRAF, active BRAF/CRAF dimers, and chaperone complexes.
- Detailed the transition of BRAF between regulatory states, involving specific domains and 14-3-3 dimers.
- Described the role of HSP90/CDC37 in stabilizing RAF proteins and facilitating dephosphorylation.
Conclusions:
- RAF regulation is complex, involving autoinhibition, dimerization, and chaperone-mediated processes.
- Understanding these regulatory mechanisms provides insights into cancer and RASopathy.
- Differences in BRAF and CRAF regulation contribute to their roles in human diseases.
More Related Videos
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Related Concept Videos
MAPK Signaling Cascades
Receptor Tyrosine Kinases
PI3K/mTOR/AKT Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...